Back to Search Start Over

Valine metabolites analysis in ECHS1 deficiency

Authors :
Naomichi Matsumoto
Takanori Yamagata
Yusuke Hamada
Shumpei Uchino
Kei Murayama
Noriko Miyake
Akira Ohtake
Mari Kuwajima
Tomomi Ogata
Yoshihito Kishita
Eriko F. Jimbo
Karin Kojima
Yasushi Okazaki
Yukiko Yatsuka
Miyuki Watanabe
Masakazu Kohda
Shiho Aoki
Masakazu Mimaki
Keiko Ichimoto
Takuya Fushimi
Kazuhiro Muramatsu
Ikuko Sato-Shirai
Hitoshi Osaka
Source :
Molecular Genetics and Metabolism Reports, Molecular Genetics and Metabolism Reports, Vol 29, Iss, Pp 100809-(2021)
Publication Year :
2021
Publisher :
Elsevier BV, 2021.

Abstract

Short-chain enoyl-CoA hydratase (ECHS1) is involved in amino acid and fatty acid catabolism in mitochondria and its deficiency causes Leigh syndrome or exercise-induced dystonia. More than 60 patients with this condition have been reported till date. The accumulation of intermediate metabolites of valine is assumed to be responsible for the cytotoxicity. Since protein restriction, including valine reportedly improves neurological symptoms, it is essential to consider the possible incidence of and diagnose ECHS1 syndrome in the earlier stages. This study reported the liquid chromatography with tandem mass spectrometry (LC-MS/MS) urine and plasma metabolite analysis in six cases, including four new cases with ECHS1 deficiency. The values of urine cysteine/cysteamine conjugates from valine metabolites, S-(2-carboxypropyl) cysteine/cysteamine from methacrylyl-CoA, and S-(2-carboxyethyl) cysteine/cysteamine from acryloyl-CoA were separated between six patients and six normal controls. The LC-MS/MS analysis revealed that these metabolites can be used for the early diagnosis and evaluation of diet therapy.

Details

ISSN :
22144269
Volume :
29
Database :
OpenAIRE
Journal :
Molecular Genetics and Metabolism Reports
Accession number :
edsair.doi.dedup.....675ecc5e25218922a70dea00dcd35285